Associated Papers
Venetoclax is effective for chronic myelomonocytic leukemia blastic transformation with RUNX1 mutation.
Kashima E et al.
Hematology (amsterdam, Netherlands), 2024
Complex landscape of alternative splicing in myeloid neoplasms.
Hershberger CE et al.
Leukemia, 2021
A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.
Brooks AN et al.
Plos One, 2014
24498085 (PubMed )
Supplement: pone.0087361.s001.pdf
Select a paper to view details